Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for subacute incomplete traumatic spinal cord injury
IRCT201407177441N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in acute spinal cord injury (SCI) comparing G-CSF with Placebo (2 arms). Primary endpoint: Motor and sensory changes according to ASIA. Started Aug 2015; status: completed.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
acute spinal cord injury (SCI)
Beyond the preview
Go deeper on IRCT201407177441N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201407177441N3.